Prognostic value of monitoring tumour markers CA 15-3 and CEA during fulvestrant treatment

BACKGROUND: At many centres tumour markers are used to detect disease recurrence and to monitor response to therapy in patients with advanced disease, although the real value of serial observation of marker levels remains disputed. In this study, we evaluated the prognostic value of tumour markers f...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartsch, Rupert, Wenzel, Catharina, Pluschnig, Ursula, Hussian, Dagmar, Sevelda, Ursula, Altorjai, Gabriela, Locker, Gottfried J, Mader, Robert, Zielinski, Christoph C, Steger, Guenther G
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1435763/
https://www.ncbi.nlm.nih.gov/pubmed/16563172
http://dx.doi.org/10.1186/1471-2407-6-81

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1435763/
https://www.ncbi.nlm.nih.gov/pubmed/16563172
http://dx.doi.org/10.1186/1471-2407-6-81

Ejemplares similares